9
Participants
Start Date
June 30, 2009
Primary Completion Date
February 28, 2011
Study Completion Date
December 31, 2011
"Bevacizumab in combination with modified FOLFOX6."
Oxaliplatin 85 mg/m2 IV on Day 1 5-FU: 400 mg/m2 IV bolus on Day 1, followed by 2400 mg/M2 over 46 hours Leucovorin: 400 mg IV Day 1 Bevacizumab: 10 mg/kg IV on Day 1 Repeat cycles every 2 weeks until death, disease progression, unacceptable toxicity, patient refusal, or treatment delay \> 4 weeks
Georgetown University Medical Center, Washington D.C.
Collaborators (1)
Sanofi
INDUSTRY
Georgetown University
OTHER